These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29122712)

  • 41. The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability.
    Ma Y; Zhao X; Li J; Shen Q
    Int J Nanomedicine; 2012; 7():559-70. PubMed ID: 22346351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
    Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH
    Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin.
    Lopes M; Shrestha N; Correia A; Shahbazi MA; Sarmento B; Hirvonen J; Veiga F; Seiça R; Ribeiro A; Santos HA
    J Control Release; 2016 Jun; 232():29-41. PubMed ID: 27074369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design of smart GE11-PLGA/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: synthesis, preparation and in vitro/ex vivo characterization.
    Colzani B; Speranza G; Dorati R; Conti B; Modena T; Bruni G; Zagato E; Vermeulen L; Dakwar GR; Braeckmans K; Genta I
    Int J Pharm; 2016 Sep; 511(2):1112-23. PubMed ID: 27511710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-D,L-lactide-co-glycolide (PLGA) nanoparticles.
    Nguyen HT; Tran TH; Kim JO; Yong CS; Nguyen CN
    Arch Pharm Res; 2015; 38(5):716-24. PubMed ID: 24968925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
    Fatma S; Talegaonkar S; Iqbal Z; Panda AK; Negi LM; Goswami DG; Tariq M
    Drug Deliv; 2016; 23(2):500-11. PubMed ID: 24937381
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa--Pharmaceutical Characterization and Fluorescence Imaging.
    Ali H; Weigmann B; Collnot EM; Khan SA; Windbergs M; Lehr CM
    Pharm Res; 2016 May; 33(5):1085-92. PubMed ID: 26718953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Film-nanoparticle composite for enhanced oral delivery of alpha-casozepine.
    Castro PM; Baptista P; Zuccheri G; Madureira AR; Sarmento B; Pintado ME
    Colloids Surf B Biointerfaces; 2019 Sep; 181():149-157. PubMed ID: 31128515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
    Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.
    Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Chu L; Yan X; Zhao M; Zhang X; Mu H; Sun K
    Mol Pharm; 2019 Feb; 16(2):518-532. PubMed ID: 30601014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The binary complex of poly(PEGMA-co-MAA) hydrogel and PLGA nanoparticles as a novel oral drug delivery system for ibuprofen delivery.
    Shang Q; Huang S; Zhang A; Feng J; Yang S
    J Biomater Sci Polym Ed; 2017 Nov; 28(16):1874-1887. PubMed ID: 28693380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy.
    Du Y; Tian C; Wang M; Huang D; Wei W; Liu Y; Li L; Sun B; Kou L; Kan Q; Liu K; Luo C; Sun J; He Z
    Drug Deliv; 2018 Nov; 25(1):1403-1413. PubMed ID: 29890854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
    J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study of Antimicrobial Effects of Clarithromycin Loaded PLGA Nanoparticles against Clinical Strains of Helicobacter pylori.
    Lotfipour F; Valizadeh H; Milani M; Bahrami N; Ghotaslou R
    Drug Res (Stuttg); 2016 Jan; 66(1):41-5. PubMed ID: 25919643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
    Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
    J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Formulation and in vitro evaluation of niacin-loaded nanoparticles to reduce prostaglandin mediated vasodilatory flushing.
    Cooper DL; Carmical JA; Panus PC; Harirforoosh S
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(20):3977-88. PubMed ID: 26531288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statistical design for formulation optimization of hydrocortisone butyrate-loaded PLGA nanoparticles.
    Yang X; Patel S; Sheng Y; Pal D; Mitra AK
    AAPS PharmSciTech; 2014 Jun; 15(3):569-87. PubMed ID: 24504495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity.
    Jain AK; Thanki K; Jain S
    Mol Pharm; 2013 Sep; 10(9):3459-74. PubMed ID: 23927416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of β-cyclodextrin on the internalization of nanoparticles into intestine epithelial cells.
    García-González L; Yépez-Mulía L; Ganem A
    Eur J Pharm Sci; 2016 Jan; 81():113-8. PubMed ID: 26478186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.